Zai Lab (ZLAB) Free Cash Flow (2020 - 2026)
Zai Lab's (ZLAB) quarterly Free Cash Flow came in at -$13.1 million in Q1 2026, up 79.27% year-on-year from -$7.3 million in Q1 2025, and up 50.91% quarter-over-quarter from -$26.7 million in Q4 2025.
Zai Lab (ZLAB) Free Cash Flow (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Free Cash Flow across 7 years of filings, most recently posting -$13.1 million for Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$13.1 million, up 79.27% year-over-year; the trailing twelve-month figure through Mar 2026 was -$108.8 million (up 43.55% YoY), and the FY2025 annual result was -$158.9 million, up 27.95% from the prior year.
- Free Cash Flow came in at -$13.1 million for Q1 2026 at Zai Lab, up from -$26.7 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$13.1 million in Q1 2026 to a low of -$133.0 million in Q3 2022.
- The 5-year median for Free Cash Flow is -$57.0 million (2023), against an average of -$58.2 million.
- Across the five-year window, Free Cash Flow surged 86.69% in 2023 and slumped 285.55% in 2024, its largest moves.
- Zai Lab's Free Cash Flow stood at -$113.7 million in 2022, then soared by 86.69% to -$15.1 million in 2023, then plunged by 285.55% to -$58.4 million in 2024, then jumped by 54.26% to -$26.7 million in 2025, then jumped by 50.91% to -$13.1 million in 2026.
- The last three Free Cash Flow figures came in at -$13.1 million (Q1 2026), -$26.7 million (Q4 2025), and -$35.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | -13.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.11 Mn |
| Mar 31, 2026 | -13.11 Mn |
| Dec 31, 2025 | -26.70 Mn |
| Dec 31, 2025 | -26.70 Mn |
| Sep 30, 2025 | -35.05 Mn |
| Sep 30, 2025 | -35.05 Mn |
| Jun 30, 2025 | -33.91 Mn |
| Jun 30, 2025 | -33.91 Mn |
| Mar 31, 2025 | -63.23 Mn |
| Mar 31, 2025 | -63.23 Mn |
| Dec 31, 2024 | -58.37 Mn |
| Dec 31, 2024 | -58.37 Mn |
| Sep 30, 2024 | -28.16 Mn |
| Sep 30, 2024 | -28.16 Mn |
| Jun 30, 2024 | -42.91 Mn |
| Jun 30, 2024 | -42.91 Mn |
| Mar 31, 2024 | -91.08 Mn |
| Mar 31, 2024 | -91.08 Mn |
| Dec 31, 2023 | -15.14 Mn |
| Dec 31, 2023 | -15.14 Mn |